A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants

Trial Identifier:	D7260C00028
Sponsor:	AstraZeneca
Collaborator:	Parexel
Start Date:	April 2026
Primary Completion Date:	September 2026
Study Completion Date:	September 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, CA	Glendale, CA, US, 91206
US, MD	Brooklyn, MD, US, 21225

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.